DrugPatentWatch Database Preview
Drugs in Development Information for Encainide
» See Plans and Pricing
What is the drug development status for Encainide?
Encainide is an investigational drug.
There have been 3 clinical trials for Encainide.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 1986.
The most common disease conditions in clinical trials are Heart Diseases, Cardiovascular Diseases, and Infarction. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), University of Washington, and [disabled in preview].
Summary for Encainide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 860 |
| WIPO Patent Applications | 1,177 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (1986-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Encainide
| Title | Sponsor | Phase |
|---|---|---|
| Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) | University of Washington | Phase 3 |
| Cardiac Arrhythmia Suppression Trial (CAST) | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
Clinical Trial Summary for Encainide
Top disease conditions for Encainide
Top clinical trial sponsors for Encainide
US Patents for Encainide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
